Pulmonary cryptococcosis

被引:96
作者
Jarvis, Joseph N. [1 ]
Harrison, Thomas S. [1 ]
机构
[1] St Georges Univ London, Ctr Infect, Dept Cellular & Mol Med, London SW17 0RE, England
基金
英国惠康基金;
关键词
Cryptococcus; cryptococcosis; pulmonary; pneumonia; HIV; epidemiology; clinical presentation; therapy;
D O I
10.1055/s-2008-1063853
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Cryptococcosis is a common opportunistic infection in acquired immunodeficiency syndrome (AIDS) patients, also occurring in other immunosuppressed patients and occasionally those with no apparent immunocompromise. The majority of cases are caused by the ubiquitous encapsulated yeast, Cryptococcus neoformans, whereas Cryptococcus gattil accounts for a smaller proportion of cases, often in immunocompetent patients. Severe meningoencephalitis is the commonest presentation; however, pulmonary cryptococcosis in human immunodeficiency virus (HIV)-seropositive individuals is underdiagnosed and without appropriate treatment leads to severe disseminated disease. The natural history of pulmonary cryptococcal infection in other immunosuppressed patients is also of dissemination and progression in the majority of cases, whereas immunocompetent patients may present with more localized, self-limiting disease. The presentation is usually with nonspecific respiratory symptoms, although severe respiratory failure has been reported in both immunocompromised and immunocompetent patients. Radiological presentations are varied and nonspecific, influenced by the underlying immune status of the patient.11ptococcus from, or detect on of cryptococcal antigen Diagnosis is based on isolation of Cry 1 in, a pulmonary specimen, coupled with appropriate clinical, radiological, and histopathological findings. Antifungal treatment with amphotericin B +/- flucytosine is recommended for severe disease, whereas fluconazole is the treatment of choice for mild and localized infections.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 118 条
[1]   Pulmonary cryptococcosis in patients without HIV infection [J].
Aberg, JA ;
Mundy, LM ;
Powderly, WG .
CHEST, 1999, 115 (03) :734-740
[2]   Pulmonary cryptococcosis in normal hosts - Treat or observe? [J].
Aberg, JA .
CHEST, 2003, 124 (06) :2049-2051
[3]   A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy [J].
Aberg, JA ;
Price, RW ;
Heeren, DM ;
Bredt, B .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (08) :1179-1182
[4]  
BAKER RD, 1976, AM J CLIN PATHOL, V65, P83
[5]   PULMONARY CRYPTOCOCCOSIS ASSOCIATED WITH HIV-1 INFECTION IN RWANDA - A RETROSPECTIVE STUDY OF 37 CASES [J].
BATUNGWANAYO, J ;
TAELMAN, H ;
BOGAERTS, J ;
ALLEN, S ;
LUCAS, S ;
KAGAME, A ;
CLERINX, J ;
MONTANE, J ;
SARAUX, A ;
MUHLBERGER, F ;
VANDEPERRE, P .
AIDS, 1994, 8 (09) :1271-1276
[6]   DETECTION OF CRYPTOCOCCAL ANTIGEN IN BRONCHOALVEOLAR LAVAGE FLUID - A PROSPECTIVE-STUDY OF DIAGNOSTIC UTILITY [J].
BAUGHMAN, RP ;
RHODES, JC ;
DOHN, MN ;
HENDERSON, H ;
FRAME, PT .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (05) :1226-1229
[7]   Unanticipated diagnoses found at autopsy in an urban public teaching hospital [J].
Bernicker, EH ;
Atmar, RL ;
Schaffner, DL ;
Greenberg, SB .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1996, 311 (05) :215-220
[8]  
Brouwer Annemarie E, 2007, J Infect, V54, pe165, DOI 10.1016/j.jinf.2006.10.002
[9]   Acute respiratory distress syndrome due to Cryptococcus albidus pneumonia:: Case report and review of the literature [J].
Burnik, C. ;
Altintas, N. D. ;
Oezkaya, G. ;
Serter, T. ;
Selcuk, Z. T. ;
Firat, P. ;
Arikan, S. ;
Cuenca-Estrella, M. ;
Topeli, A. .
MEDICAL MYCOLOGY, 2007, 45 (05) :469-473
[10]  
CAMERON ML, 1991, REV INFECT DIS, V13, P64